GNMLF Stock Genomma Lab International SAB DE CV (GNMLF, $1.17) was a top weekly gainer, with a +7.34% jump

GET DAILY SIGNALS

Get AI intraday signals

GNMLF - Genomma Lab International SAB DE CV

Loading...

Price: $1.17

Daily change: +$0.08 (+7.34%)

Daily volume: 100

Weekly price change: +$0.08 (+7.34%)

Capitalization: $1.1B

Industry: Pharmaceuticals: Other

GNMLF sees MACD Histogram crosses below signal line

GNMLF saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 21, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 24 instances where the indicator turned negative. In of the 24 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Technical Analysis (Indicators)

Bearish Trend Analysis

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In of 92 cases where GNMLF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.868) is normal, around the industry mean (17.057). P/E Ratio (11.377) is within average values for comparable stocks, (73.476). Projected Growth (PEG Ratio) (0.463) is also within normal values, averaging (1.956). Dividend Yield (0.035) settles around the average of (0.030) among similar stocks. P/S Ratio (1.114) is also within normal values, averaging (46.215).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GNMLF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GNMLF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.